Please assess the completion status of the following clinical trial:

Trial Title: Gastrointestinal Motility Among Diabetes Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria: (only patients)~* Subject is suffering from diabetes~* Gastrointestinal symptoms including diarrhoea, nausea, vomiting, bloating and abdominal discomfort)~* Subject \> 18 years of age who possess capacity to understand subject information sheet and give informed consent for participation~* Fasted since midnight until morning 8 o´clock~Exclusion Criteria:~* Dysregulated metabolic disease~* Structuring bowel disease or obvious stenotic symptoms or perforation~* Subject has known swallowing disorders~* Subject has cancer or other life threatening diseases or conditions~* Subject is pregnant or breastfeeding~* Subject has undergone extensive abdominal surgery~* Subject has a abdominal diameter \> 140 cm~* Drug abuse or alcoholism~* Bacterial overgrowth~* Subject has known severe cardiovascular or pulmonary diseases (including artificial pacemaker and/or implantable cardioverter-defibrillator (ICD))~* Central nerve system (CNS) surgery~* Patient have infusion pump or other implantable medical device~* Medication (not possible for pausing for 48 hours) or any other disease affecting motility or/and gastroparesis.~* Subjects having MRI within the next four weeks~* Taking corticosteroids during the last month~* Allergic reaction to Pyridostigmine and/or intravenously administrated contrast~* Severe upper gastrointestinal pathology seen by endoscopy~* Blood glucose below 4 mmol/L or higher than 10 mmol/L right before examination~* Bile acid malabsorption or malabsorption in general~* Obstruction of the urinary system~* Severe renal insufficiency (eGFR \< 45)~* Peritonitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Diabetic patient (Type: ACTIVE_COMPARATOR): The study consists of four different parts:~1. 11C Donepezil PET/CT scan~2. 3D-Transit~3. 3D-Transit during treatment with pyridostigmine~4. 3D-Transit after Malone appendicostomy (only diabetic patients who had a Malone-surgery for severe obstipation ordered during standard clinical practice)
- Healthy subjects (Type: ACTIVE_COMPARATOR): The study consists of two different parts:~1. 11C Donepezil PET/CT scan~2. 3D-Transit

Based on this trial design, predict the completion outcome and termination type (if applicable).